Login / Signup
Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.
Aditya Kumar Panda
Sunali Padhi
Abhijit Pati
Tapan Kumar Singh Nayak
Published in:
Human cell (2021)
Keyphrases
</>
randomized controlled trial
sars cov
combination therapy
study protocol
replacement therapy